These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 34611930)
1. Loss of protein association causes cardiolipin degradation in Barth syndrome. Xu Y; Phoon CK; Berno B; D'Souza K; Hoedt E; Zhang G; Neubert TA; Epand RM; Ren M; Schlame M Nat Chem Biol; 2016 Aug; 12(8):641-7. PubMed ID: 27348092 [TBL] [Abstract][Full Text] [Related]
2. Cardiolipin, the heart of mitochondrial metabolism. Houtkooper RH; Vaz FM Cell Mol Life Sci; 2008 Aug; 65(16):2493-506. PubMed ID: 18425414 [TBL] [Abstract][Full Text] [Related]
3. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures. Liu O; Chinni BK; Manlhiot C; Vernon HJ Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445 [TBL] [Abstract][Full Text] [Related]
4. Phospholipids can regulate complex I assembly independent of their role in maintaining mitochondrial membrane integrity. Murari A; Rhooms SK; Vimal D; Hossain KFB; Saini S; Villanueva M; Schlame M; Owusu-Ansah E Cell Rep; 2023 Aug; 42(8):112846. PubMed ID: 37516961 [TBL] [Abstract][Full Text] [Related]
5. Cardiolipin prolongs the lifetimes of respiratory proteins in Drosophila flight muscle. Ren M; Xu Y; Phoon CKL; Erdjument-Bromage H; Neubert TA; Schlame M J Biol Chem; 2023 Oct; 299(10):105241. PubMed ID: 37690688 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial membrane model: Lipids, elastic properties, and the changing curvature of cardiolipin. Konar S; Arif H; Allolio C Biophys J; 2023 Nov; 122(21):4274-4287. PubMed ID: 37798880 [TBL] [Abstract][Full Text] [Related]
7. Structure and Elasticity of Mitochondrial Membranes: A Molecular Dynamics Simulation Study. Mai TL; Derreumaux P; Nguyen PH J Phys Chem B; 2023 Dec; 127(50):10778-10791. PubMed ID: 38084584 [TBL] [Abstract][Full Text] [Related]
8. A monolysocardiolipin-cytochrome c peroxidase causes defects in Barth syndrome. Nat Metab; 2023 Dec; 5(12):2043-2044. PubMed ID: 38049582 [No Abstract] [Full Text] [Related]
9. Current and future treatment approaches for Barth syndrome. Thompson R; Jefferies J; Wang S; Pu WT; Takemoto C; Hornby B; Heyman A; Chin MT; Vernon HJ J Inherit Metab Dis; 2022 Jan; 45(1):17-28. PubMed ID: 34713454 [TBL] [Abstract][Full Text] [Related]
10. Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid. Sabbah HN Heart Fail Rev; 2022 Sep; 27(5):1911-1923. PubMed ID: 34623544 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion. Tomczewski MV; Chan JZ; Al-Majmaie DM; Liu MR; Cocco AD; Stark KD; Strathdee D; Duncan RE Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759637 [TBL] [Abstract][Full Text] [Related]
12. A simple mechanistic explanation for Barth syndrome and cardiolipin remodeling. Xu Y; Phoon CKL; Ren M; Schlame M J Inherit Metab Dis; 2022 Jan; 45(1):51-59. PubMed ID: 34611930 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome. Gebert N; Joshi AS; Kutik S; Becker T; McKenzie M; Guan XL; Mooga VP; Stroud DA; Kulkarni G; Wenk MR; Rehling P; Meisinger C; Ryan MT; Wiedemann N; Greenberg ML; Pfanner N Curr Biol; 2009 Dec; 19(24):2133-9. PubMed ID: 19962311 [TBL] [Abstract][Full Text] [Related]